Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06525259 · ClinicalTrials.gov registry record
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
A clinical trial of Diabetes Mellitus Type 2, Childhood-Onset, sponsored by George Washington University.
- Recruiting
- Registry status
- 3,600
- Enrollment target
- 20
- Study locations
NCT06525259: Recruiting study of Diabetes Mellitus Type 2, Childhood-Onset, sponsored by George Washington University.
NCT06525259 is a study of Diabetes Mellitus Type 2, Childhood-Onset that is actively recruiting participants, run by George Washington University. The registered enrollment target is 3,600 participants. The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06525259, a study of Diabetes Mellitus Type 2, Childhood-Onset, is actively recruiting participants, sponsored by George Washington University.
- RECRUITING
- Registry status
- 3,600 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic determinates, in obese adolescents at risk for developing type 2 diabetes.
Primary Outcome
Development of type 2 diabetes, as defined by a hemoglobin A1c (HbA1c) ≥6.5% at an annual or mid-year visit followed by a confirmatory HbA1c ≥6.5% collected within 2 weeks of the first value.
Conditions Studied
Study Locations (20)
New York
- NYU Langone Health- Brooklyn - Brooklyn
- NYU Langone Health- Long Island - Garden City
- NYU Langone Health- Manhattan - New York
- Albert Einstein College of Medicine - The Bronx
Arizona
- Arizona State University - Phoenix
- Phoenix Children's - Phoenix
North Carolina
- Atrium Health - Charlotte
- Wake Forest University - Winston-Salem
Ohio
- Cincinnati Children's Hospital - Cincinnati
- Nationwide Children's Hospital - Columbus
Alabama
- University of Alabama at Birmingham - Birmingham
California
- Children's Hospital Los Angeles - Los Angeles
Colorado
- Children's Hospital Colorado - Aurora
Florida
- Johns Hopkins All Children's Hospital - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,600 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2028-01-31 |
What NCT06525259 shows while recruiting
NCT06525259 is an observational study that tracks outcomes without assigning an intervention. Its 3,600 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Diabetes Mellitus Type 2, Childhood-Onset appearing as the primary indexed condition, and to 0 interventions.
NCT06525259 names 20 study sites across 14 states, led by New York, Arizona, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06525259 about?
NCT06525259 is a clinical study titled "DISCOVERY of Risk Factors for Type 2 Diabetes in Youth". The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic determinates, in obese adolescents at risk for developing type 2 diabetes.
What is the current status of trial NCT06525259?
This trial is currently recruiting. The enrollment target is 3,600 participants. The study started on 2024-10-01. Estimated completion is 2028-01-31.
What conditions does trial NCT06525259 study?
This clinical trial studies the following conditions: Diabetes Mellitus Type 2, Childhood-Onset.
Who is sponsoring clinical trial NCT06525259?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06525259 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06088498 · 3,600 participants · Phase 2
App for Reducing Cravings to Smoke
- NCT06501118 · 3,600 participants · NA
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
- NCT06919419 · 3,600 participants · NA
HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy
- NCT07091032 · 3,600 participants · NA
Building Connections
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI